Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics-Reference-Cited by-同舟云学术

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics

Published:2012-01-28 Issue:1 Volume:3 Page:84-97
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

McDonald Paul C.¹,Winum Jean-Yves²,Supuran Claudiu T.³,Dedhar Shoukat¹⁴

Affiliation:

1. Department of Integrative Oncology, BC Cancer Research Centre and BC Cancer Agency, Vancouver, BC, Canada

2. Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS-UM1-UM2, Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Chimie de Montpellier, 8 rue de l'Ecole Normale, 34296 Montpellier Cedex, France

3. Laboritario di Chimica Bioinorganica, Universita degli Studi di Firenze, Italy

4. Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 358 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Nitric Oxide-Donating Benzofuroxans for Targeted Inhibition of Carbonic Anhydrase IX in Cancer;Journal of Medicinal Chemistry;2024-08-29

2. Synthesis and Carbonic Anhydrase I, II, IX, and XII Inhibition Studies with a Series of Cyclic Sulfonyl Guanidines;ChemMedChem;2024-08-21

3. IL-22 regulates MASTL expression in intestinal epithelial cells;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-08-01

4. Radiotheranostics Global Market and Future Developments;Seminars in Nuclear Medicine;2024-07

5. Carbonic anhydrase IX: An atypical target for innovative therapies in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07